Industry Research Reports
Home > Reports > Medical Devices & Consumables > IVD Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
IVD Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 101 Pages
Report ld: 3498351
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
IVD Antibody Market Size(US$)
CAGR 2025-2031
8%
Market Size,2031
USD 1,585
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 999 million
Market Forecast in 2031(Value)
US$ 1,585 million
CAGR
8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for IVD Antibody was estimated to be worth US$ 932 million in 2024 and is forecast to a readjusted size of US$ 1585 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
IVD Antibody
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for IVD Antibody, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of IVD Antibody by region & country, by Type, and by Application.
The IVD Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Antibody.
MARKET SEGMENTATION
By Company
- BD PharMingen
- Abcam
- R&D Systems
- Cell Signaling Technology
- Affymatrix
- BioLegend
- Santa Cruz Biotechnologies
- Beckman Coulter
- Roche/Ventana
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- mAb
- pAb
- rAbs
Segment by Application
- RIA
- ELISA
- CLIA
- LFIA
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of IVD Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of IVD Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of IVD Antibody in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 IVD Antibody Product Introduction
1.2 Global IVD Antibody Market Size Forecast
1.2.1 Global IVD Antibody Sales Value (2020-2031)
1.2.2 Global IVD Antibody Sales Volume (2020-2031)
1.2.3 Global IVD Antibody Sales Price (2020-2031)
1.3 IVD Antibody Market Trends & Drivers
1.3.1 IVD Antibody Industry Trends
1.3.2 IVD Antibody Market Drivers & Opportunity
1.3.3 IVD Antibody Market Challenges
1.3.4 IVD Antibody Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global IVD Antibody Players Revenue Ranking (2024)
2.2 Global IVD Antibody Revenue by Company (2020-2025)
2.3 Global IVD Antibody Players Sales Volume Ranking (2024)
2.4 Global IVD Antibody Sales Volume by Company Players (2020-2025)
2.5 Global IVD Antibody Average Price by Company (2020-2025)
2.6 Key Manufacturers IVD Antibody Manufacturing Base and Headquarters
2.7 Key Manufacturers IVD Antibody Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of IVD Antibody
2.9 IVD Antibody Market Competitive Analysis
2.9.1 IVD Antibody Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by IVD Antibody Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Antibody as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 mAb
3.1.2 pAb
3.1.3 rAbs
3.2 Global IVD Antibody Sales Value by Type
3.2.1 Global IVD Antibody Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global IVD Antibody Sales Value, by Type (2020-2031)
3.2.3 Global IVD Antibody Sales Value, by Type (%) (2020-2031)
3.3 Global IVD Antibody Sales Volume by Type
3.3.1 Global IVD Antibody Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global IVD Antibody Sales Volume, by Type (2020-2031)
3.3.3 Global IVD Antibody Sales Volume, by Type (%) (2020-2031)
3.4 Global IVD Antibody Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 RIA
4.1.2 ELISA
4.1.3 CLIA
4.1.4 LFIA
4.1.5 Other
4.2 Global IVD Antibody Sales Value by Application
4.2.1 Global IVD Antibody Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global IVD Antibody Sales Value, by Application (2020-2031)
4.2.3 Global IVD Antibody Sales Value, by Application (%) (2020-2031)
4.3 Global IVD Antibody Sales Volume by Application
4.3.1 Global IVD Antibody Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global IVD Antibody Sales Volume, by Application (2020-2031)
4.3.3 Global IVD Antibody Sales Volume, by Application (%) (2020-2031)
4.4 Global IVD Antibody Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global IVD Antibody Sales Value by Region
5.1.1 Global IVD Antibody Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global IVD Antibody Sales Value by Region (2020-2025)
5.1.3 Global IVD Antibody Sales Value by Region (2026-2031)
5.1.4 Global IVD Antibody Sales Value by Region (%), (2020-2031)
5.2 Global IVD Antibody Sales Volume by Region
5.2.1 Global IVD Antibody Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global IVD Antibody Sales Volume by Region (2020-2025)
5.2.3 Global IVD Antibody Sales Volume by Region (2026-2031)
5.2.4 Global IVD Antibody Sales Volume by Region (%), (2020-2031)
5.3 Global IVD Antibody Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America IVD Antibody Sales Value, 2020-2031
5.4.2 North America IVD Antibody Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe IVD Antibody Sales Value, 2020-2031
5.5.2 Europe IVD Antibody Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific IVD Antibody Sales Value, 2020-2031
5.6.2 Asia Pacific IVD Antibody Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America IVD Antibody Sales Value, 2020-2031
5.7.2 South America IVD Antibody Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa IVD Antibody Sales Value, 2020-2031
5.8.2 Middle East & Africa IVD Antibody Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions IVD Antibody Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions IVD Antibody Sales Value
6.2.1 Key Countries/Regions IVD Antibody Sales Value, 2020-2031
6.2.2 Key Countries/Regions IVD Antibody Sales Volume, 2020-2031
6.3 United States
6.3.1 United States IVD Antibody Sales Value, 2020-2031
6.3.2 United States IVD Antibody Sales Value by Type (%), 2024 VS 2031
6.3.3 United States IVD Antibody Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe IVD Antibody Sales Value, 2020-2031
6.4.2 Europe IVD Antibody Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe IVD Antibody Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China IVD Antibody Sales Value, 2020-2031
6.5.2 China IVD Antibody Sales Value by Type (%), 2024 VS 2031
6.5.3 China IVD Antibody Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan IVD Antibody Sales Value, 2020-2031
6.6.2 Japan IVD Antibody Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan IVD Antibody Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea IVD Antibody Sales Value, 2020-2031
6.7.2 South Korea IVD Antibody Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea IVD Antibody Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia IVD Antibody Sales Value, 2020-2031
6.8.2 Southeast Asia IVD Antibody Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia IVD Antibody Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India IVD Antibody Sales Value, 2020-2031
6.9.2 India IVD Antibody Sales Value by Type (%), 2024 VS 2031
6.9.3 India IVD Antibody Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 BD PharMingen
7.1.1 BD PharMingen Company Information
7.1.2 BD PharMingen Introduction and Business Overview
7.1.3 BD PharMingen IVD Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 BD PharMingen IVD Antibody Product Offerings
7.1.5 BD PharMingen Recent Development
7.2 Abcam
7.2.1 Abcam Company Information
7.2.2 Abcam Introduction and Business Overview
7.2.3 Abcam IVD Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Abcam IVD Antibody Product Offerings
7.2.5 Abcam Recent Development
7.3 R&D Systems
7.3.1 R&D Systems Company Information
7.3.2 R&D Systems Introduction and Business Overview
7.3.3 R&D Systems IVD Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 R&D Systems IVD Antibody Product Offerings
7.3.5 R&D Systems Recent Development
7.4 Cell Signaling Technology
7.4.1 Cell Signaling Technology Company Information
7.4.2 Cell Signaling Technology Introduction and Business Overview
7.4.3 Cell Signaling Technology IVD Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Cell Signaling Technology IVD Antibody Product Offerings
7.4.5 Cell Signaling Technology Recent Development
7.5 Affymatrix
7.5.1 Affymatrix Company Information
7.5.2 Affymatrix Introduction and Business Overview
7.5.3 Affymatrix IVD Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Affymatrix IVD Antibody Product Offerings
7.5.5 Affymatrix Recent Development
7.6 BioLegend
7.6.1 BioLegend Company Information
7.6.2 BioLegend Introduction and Business Overview
7.6.3 BioLegend IVD Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 BioLegend IVD Antibody Product Offerings
7.6.5 BioLegend Recent Development
7.7 Santa Cruz Biotechnologies
7.7.1 Santa Cruz Biotechnologies Company Information
7.7.2 Santa Cruz Biotechnologies Introduction and Business Overview
7.7.3 Santa Cruz Biotechnologies IVD Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Santa Cruz Biotechnologies IVD Antibody Product Offerings
7.7.5 Santa Cruz Biotechnologies Recent Development
7.8 Beckman Coulter
7.8.1 Beckman Coulter Company Information
7.8.2 Beckman Coulter Introduction and Business Overview
7.8.3 Beckman Coulter IVD Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Beckman Coulter IVD Antibody Product Offerings
7.8.5 Beckman Coulter Recent Development
7.9 Roche/Ventana
7.9.1 Roche/Ventana Company Information
7.9.2 Roche/Ventana Introduction and Business Overview
7.9.3 Roche/Ventana IVD Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Roche/Ventana IVD Antibody Product Offerings
7.9.5 Roche/Ventana Recent Development
8 Industry Chain Analysis
8.1 IVD Antibody Industrial Chain
8.2 IVD Antibody Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 IVD Antibody Sales Model
8.5.2 Sales Channel
8.5.3 IVD Antibody Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. IVD Antibody Market Trends
Table 2. IVD Antibody Market Drivers & Opportunity
Table 3. IVD Antibody Market Challenges
Table 4. IVD Antibody Market Restraints
Table 5. Global IVD Antibody Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global IVD Antibody Revenue Market Share by Company (2020-2025)
Table 7. Global IVD Antibody Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global IVD Antibody Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market IVD Antibody Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers IVD Antibody Manufacturing Base and Headquarters
Table 11. Key Manufacturers IVD Antibody Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of IVD Antibody
Table 13. Global IVD Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Antibody as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global IVD Antibody Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global IVD Antibody Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global IVD Antibody Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global IVD Antibody Sales Market Share in Value by Type (2020-2025)
Table 20. Global IVD Antibody Sales Market Share in Value by Type (2026-2031)
Table 21. Global IVD Antibody Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global IVD Antibody Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global IVD Antibody Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global IVD Antibody Sales Market Share in Volume by Type (2020-2025)
Table 25. Global IVD Antibody Sales Market Share in Volume by Type (2026-2031)
Table 26. Global IVD Antibody Price by Type (2020-2025) & (US$/Unit)
Table 27. Global IVD Antibody Price by Type (2026-2031) & (US$/Unit)
Table 28. Global IVD Antibody Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global IVD Antibody Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global IVD Antibody Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global IVD Antibody Sales Market Share in Value by Application (2020-2025)
Table 32. Global IVD Antibody Sales Market Share in Value by Application (2026-2031)
Table 33. Global IVD Antibody Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global IVD Antibody Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global IVD Antibody Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global IVD Antibody Sales Market Share in Volume by Application (2020-2025)
Table 37. Global IVD Antibody Sales Market Share in Volume by Application (2026-2031)
Table 38. Global IVD Antibody Price by Application (2020-2025) & (US$/Unit)
Table 39. Global IVD Antibody Price by Application (2026-2031) & (US$/Unit)
Table 40. Global IVD Antibody Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global IVD Antibody Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global IVD Antibody Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global IVD Antibody Sales Value by Region (2020-2025) & (%)
Table 44. Global IVD Antibody Sales Value by Region (2026-2031) & (%)
Table 45. Global IVD Antibody Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global IVD Antibody Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global IVD Antibody Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global IVD Antibody Sales Volume by Region (2020-2025) & (%)
Table 49. Global IVD Antibody Sales Volume by Region (2026-2031) & (%)
Table 50. Global IVD Antibody Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global IVD Antibody Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions IVD Antibody Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions IVD Antibody Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions IVD Antibody Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions IVD Antibody Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions IVD Antibody Sales Volume, (2026-2031) & (K Units)
Table 57. BD PharMingen Company Information
Table 58. BD PharMingen Introduction and Business Overview
Table 59. BD PharMingen IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. BD PharMingen IVD Antibody Product Offerings
Table 61. BD PharMingen Recent Development
Table 62. Abcam Company Information
Table 63. Abcam Introduction and Business Overview
Table 64. Abcam IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Abcam IVD Antibody Product Offerings
Table 66. Abcam Recent Development
Table 67. R&D Systems Company Information
Table 68. R&D Systems Introduction and Business Overview
Table 69. R&D Systems IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. R&D Systems IVD Antibody Product Offerings
Table 71. R&D Systems Recent Development
Table 72. Cell Signaling Technology Company Information
Table 73. Cell Signaling Technology Introduction and Business Overview
Table 74. Cell Signaling Technology IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Cell Signaling Technology IVD Antibody Product Offerings
Table 76. Cell Signaling Technology Recent Development
Table 77. Affymatrix Company Information
Table 78. Affymatrix Introduction and Business Overview
Table 79. Affymatrix IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Affymatrix IVD Antibody Product Offerings
Table 81. Affymatrix Recent Development
Table 82. BioLegend Company Information
Table 83. BioLegend Introduction and Business Overview
Table 84. BioLegend IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. BioLegend IVD Antibody Product Offerings
Table 86. BioLegend Recent Development
Table 87. Santa Cruz Biotechnologies Company Information
Table 88. Santa Cruz Biotechnologies Introduction and Business Overview
Table 89. Santa Cruz Biotechnologies IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Santa Cruz Biotechnologies IVD Antibody Product Offerings
Table 91. Santa Cruz Biotechnologies Recent Development
Table 92. Beckman Coulter Company Information
Table 93. Beckman Coulter Introduction and Business Overview
Table 94. Beckman Coulter IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Beckman Coulter IVD Antibody Product Offerings
Table 96. Beckman Coulter Recent Development
Table 97. Roche/Ventana Company Information
Table 98. Roche/Ventana Introduction and Business Overview
Table 99. Roche/Ventana IVD Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Roche/Ventana IVD Antibody Product Offerings
Table 101. Roche/Ventana Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. IVD Antibody Downstream Customers
Table 105. IVD Antibody Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. IVD Antibody Product Picture
Figure 2. Global IVD Antibody Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global IVD Antibody Sales Value (2020-2031) & (US$ Million)
Figure 4. Global IVD Antibody Sales Volume (2020-2031) & (K Units)
Figure 5. Global IVD Antibody Sales Price (2020-2031) & (US$/Unit)
Figure 6. IVD Antibody Report Years Considered
Figure 7. Global IVD Antibody Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global IVD Antibody Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by IVD Antibody Revenue in 2024
Figure 10. IVD Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. mAb Picture
Figure 12. pAb Picture
Figure 13. rAbs Picture
Figure 14. Global IVD Antibody Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global IVD Antibody Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global IVD Antibody Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 17. Global IVD Antibody Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global IVD Antibody Price by Type (2020-2031) & (US$/Unit)
Figure 19. Product Picture of RIA
Figure 20. Product Picture of ELISA
Figure 21. Product Picture of CLIA
Figure 22. Product Picture of LFIA
Figure 23. Product Picture of Other
Figure 24. Global IVD Antibody Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 25. Global IVD Antibody Sales Value Market Share by Application, 2024 & 2031
Figure 26. Global IVD Antibody Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 27. Global IVD Antibody Sales Volume Market Share by Application, 2024 & 2031
Figure 28. Global IVD Antibody Price by Application (2020-2031) & (US$/Unit)
Figure 29. North America IVD Antibody Sales Value (2020-2031) & (US$ Million)
Figure 30. North America IVD Antibody Sales Value by Country (%), 2024 VS 2031
Figure 31. Europe IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe IVD Antibody Sales Value by Country (%), 2024 VS 2031
Figure 33. Asia Pacific IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 34. Asia Pacific IVD Antibody Sales Value by Region (%), 2024 VS 2031
Figure 35. South America IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 36. South America IVD Antibody Sales Value by Country (%), 2024 VS 2031
Figure 37. Middle East & Africa IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 38. Middle East & Africa IVD Antibody Sales Value by Country (%), 2024 VS 2031
Figure 39. Key Countries/Regions IVD Antibody Sales Value (%), (2020-2031)
Figure 40. Key Countries/Regions IVD Antibody Sales Volume (%), (2020-2031)
Figure 41. United States IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 42. United States IVD Antibody Sales Value by Type (%), 2024 VS 2031
Figure 43. United States IVD Antibody Sales Value by Application (%), 2024 VS 2031
Figure 44. Europe IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 45. Europe IVD Antibody Sales Value by Type (%), 2024 VS 2031
Figure 46. Europe IVD Antibody Sales Value by Application (%), 2024 VS 2031
Figure 47. China IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 48. China IVD Antibody Sales Value by Type (%), 2024 VS 2031
Figure 49. China IVD Antibody Sales Value by Application (%), 2024 VS 2031
Figure 50. Japan IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 51. Japan IVD Antibody Sales Value by Type (%), 2024 VS 2031
Figure 52. Japan IVD Antibody Sales Value by Application (%), 2024 VS 2031
Figure 53. South Korea IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 54. South Korea IVD Antibody Sales Value by Type (%), 2024 VS 2031
Figure 55. South Korea IVD Antibody Sales Value by Application (%), 2024 VS 2031
Figure 56. Southeast Asia IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 57. Southeast Asia IVD Antibody Sales Value by Type (%), 2024 VS 2031
Figure 58. Southeast Asia IVD Antibody Sales Value by Application (%), 2024 VS 2031
Figure 59. India IVD Antibody Sales Value, (2020-2031) & (US$ Million)
Figure 60. India IVD Antibody Sales Value by Type (%), 2024 VS 2031
Figure 61. India IVD Antibody Sales Value by Application (%), 2024 VS 2031
Figure 62. IVD Antibody Industrial Chain
Figure 63. IVD Antibody Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global IVD Antibody market?
The top companies in the global IVD Antibody market are BD PharMingen、Abcam、R&D Systems.
Which region is expected to have the highest market share?
What was the global market size of IVD Antibody in 2025?
What is the annual compound growth rate of the global IVD Antibody market size from 2025 to 2031?
What was the global market size of IVD Antibody in 2031?
Related Reports
IVD Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for IVD Antibody was estimated to be worth US$ 999 million in 2025 and is projected to reach US$ 1699 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 135
USD 3950.00
(Single User License)
Global IVD Antibody Market Research Report 2026
The global IVD Antibody market was valued at US$ 999 million in 2025 and is anticipated to reach US$ 1699 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 110
USD 2900.00
(Single User License)
Global IVD Antibody Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global IVD Antibody market size was US$ 932 million in 2024 and is forecast to a readjusted size of US$ 1585 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
Global IVD Antibody Market Outlook, In‑Depth Analysis & Forecast to 2031
The global IVD Antibody market is projected to grow from US$ 932 million in 2024 to US$ 1585 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 133
USD 4900.00
(Single User License)
Global IVD Antibody Market Research Report 2025
The global market for IVD Antibody was valued at US$ 932 million in the year 2024 and is projected to reach a revised size of US$ 1585 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Published Date: 2025-01-13
Pages: 83
USD 2900.00
(Single User License)
Global IVD Antibody Market Insights, Forecast to 2030
IVD Antibody
Published Date: 2024-04-15
Pages: 99
USD 4900.00
(Single User License)
Global IVD Antibody Market Research Report 2024
IVD Antibody
Published Date: 2024-01-17
Pages: 80
USD 2900.00
(Single User License)
IVD Antibody- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for IVD Antibody was estimated to be worth US$ 999 million in 2025 and is projected to reach US$ 1699 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 135
USD 3950.00 (Single User License)Global IVD Antibody Market Research Report 2026
The global IVD Antibody market was valued at US$ 999 million in 2025 and is anticipated to reach US$ 1699 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-04-17
Pages: 110
USD 2900.00 (Single User License)Global IVD Antibody Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global IVD Antibody market size was US$ 932 million in 2024 and is forecast to a readjusted size of US$ 1585 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
USD 4250.00 (Single User License)Global IVD Antibody Market Outlook, In‑Depth Analysis & Forecast to 2031
The global IVD Antibody market is projected to grow from US$ 932 million in 2024 to US$ 1585 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 133
USD 4900.00 (Single User License)Global IVD Antibody Market Research Report 2025
The global market for IVD Antibody was valued at US$ 932 million in the year 2024 and is projected to reach a revised size of US$ 1585 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Published: 2025-01-13
Pages: 83
USD 2900.00 (Single User License)Global IVD Antibody Market Insights, Forecast to 2030
IVD Antibody
Published: 2024-04-15
Pages: 99
USD 4900.00 (Single User License)Global IVD Antibody Market Research Report 2024
IVD Antibody
Published: 2024-01-17
Pages: 80
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now